BRS2-FM1-PM4 - Methionine Cycle Flux
(Balanced Methionine → SAM → SAH → Homocysteine Routing)
1. Mission & Overview
Mission
Maintain balanced methionine-cycle flux so methionine availability, SAM-dependent methylation, homocysteine recycling and transsulfuration remain coordinated across changing physiological demand.
Overview
Coordinates the methionine cycle as an integrated flux system: methionine availability → SAM synthesis → methyl transfer → SAH → homocysteine → remethylation or transsulfuration, rather than treating any single step as the goal. Methionine is an essential substrate whose adequacy enables SAM generation and downstream routing, while chronic excess is not assumed beneficial. Homocysteine is an important intermediate and practical readout of cycle strain, not the organising objective of this PM. Effective flux therefore depends on methionine adequacy within protein and amino-acid balance, methyl-donor and cofactor coverage, methylation demand, and coordinated routing between remethylation and transsulfuration.
- Balances methionine availability with SAM-dependent methylation and SAH-mediated constraint.
- Treats homocysteine as a cycle junction and readout, not the biological endpoint.
- Coordinates remethylation and transsulfuration under changing metabolic demand.
2. Primary Biological Effects
↑ coordinated methionine-cycle flux; ↔ methionine adequacy; ↑ methylation potential (SAM relative to SAH)
3. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework. Biology → Phenome Confidence reflects how directly this mechanism's biology would be expected to affect the phenome within BRAIN architecture — not dietary treatment efficacy. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Rationale: Balanced methionine-cycle flux sets methylation potential (SAM availability relative to SAH-mediated constraint) that supports phospholipid, neurotransmitter and broader methylation chemistry relevant to cognitive clarity. Homocysteine remains a useful junction readout of cycle strain, but the biology scored here is coordinated methionine → SAM → SAH → remethylation/transsulfuration flux rather than homocysteine lowering alone. Direct ADHD cognitive-clarity outcomes on integrated cycle flux remain limited (biology > evidence gap).
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Rationale: Attention-relevant one-carbon biology depends on coordinated methyl-transfer capacity under daily demand, not only on remethylation of accumulated homocysteine. Cycle flux that keeps methionine adequacy, SAM-dependent methylation and downstream recycling aligned provides translational context for focus stability when dietary methyl-donor and sulfur-amino-acid patterns are strained. Homocysteine and B-vitamin associations in ADHD-relevant cohorts remain supportive readouts of multi-step cycle stress rather than proof that this PM alone determines attention.
- Key References:
- Evidence Confidence: Low–Medium
4. Levers
Intervention Profile
Intervention Dominance: Diet-Dominant
- Methionine ← eggs, fish, poultry (adequacy within protein/amino-acid balance — not maximisation)
- Coordinated methyl-donor meal patterns (folate, B12, choline, betaine alongside methionine) → support cycle flux without treating methionine supply as an open-ended target
- Riboflavin (B2) ← dairy, eggs, lean meat
- Vitamin B6 ← poultry, fish, chickpeas
- Vitamin B12 ← shellfish, sardines, eggs
-
Folate ← leafy greens, legumes, liver
-
Choline ← eggs, liver, salmon
-
Betaine (TMG) ← beetroot, spinach, quinoa
-
Vitamin B12 ← shellfish, sardines, eggs
-
Methionine ← eggs, fish, poultry (shared-pool adequacy / balance — not higher intake by default)
-
Serine ← soy foods, eggs, turkey
-
Glycine ← gelatin-rich cuts, poultry, fish
-
Cysteine ← eggs, chicken, yogurt
1. Food Preparation & Delivery ONLY
- Consistent daily meal timing may support one-carbon and methyl-donor availability across the day.
- Soak and cook thoroughly to reduce phytates and improve mineral bioavailability; soaking and spro… — see Lentils — Preparation.
- Pair fat-soluble compounds with dietary fat to support absorption — see Spinach — Synergies.
- Best prepared with gentle cooking to preserve omega-3s and prevent oxidation — see Salmon — Preparation.
- Sleep and stress context may indirectly affect methylation demand; lifestyle factors are secondary to dietary substrate and cofactor pattern for this PM.
5. Mechanistic Basis
Summary
Methionine-cycle flux is the integrated regulation of methionine availability, SAM-dependent methyl transfer, SAH formation, and the subsequent remethylation-versus-transsulfuration branch point. The biological objective is coordinated flux under changing demand — not homocysteine clearance alone, and not open-ended methionine maximisation.
(Methionine as a regulated essential substrate)
Methionine is an essential amino acid and the substrate from which SAM is generated. Adequacy supports cycle entry and downstream methylation chemistry, but methionine biology is not “more substrate = better flux.” Dietary methionine restriction remodels systemic metabolism in experimental models, while moderate methionine within low-amino-acid patterns can preserve favourable metabolic phenotypes — implying a balance window rather than monotonic benefit from higher intake [Parkhitko et al., 2026; Fanti et al., 2026].
(SAM → methyl transfer → SAH and methylation potential)
SAM donates methyl groups to acceptors; SAH is the immediate product and a potent product inhibitor of SAM-dependent methyltransferases. Methylation potential therefore depends on SAM supply relative to SAH accumulation/clearance, not SAM output alone [Chiang et al., 1996]. This SAM:SAH logic is central to why PM4 owns integrated cycle flux rather than any single remethylation arm.
(Homocysteine as a junction and readout)
After SAH is hydrolysed, homocysteine sits at the remethylation–transsulfuration branch point. Elevated homocysteine can signal multi-step cycle strain when remethylation, cofactors or substrate pools are constrained [Luzzi et al., 2022; Yu et al., 2020]. For this PM, homocysteine is an intermediate and practical readout — not the organising biological objective (dedicated remethylation biology belongs on PM1/PM2).
(Remethylation versus transsulfuration branch decision)
Cycle flux determines whether homocysteine is recycled to methionine or diverted toward cysteine/GSH-linked sulfur-amino-acid metabolism. Transsulfuration pathway detail belongs on BRS2-FM2-PM5; PM4 owns the integrated decision context that links methionine availability and methylation demand to that branch [Kumar and Yadav, 2017; Aragão et al., 2024].
(Boundaries of the mechanism)
This PM governs integrated methionine-cycle flux and balance — a system flux node — not individual enzymatic steps.
Folate/B12 remethylation belongs to BRS2-FM1-PM1. BHMT remethylation belongs to BRS2-FM1-PM2. SAMe synthesis belongs to BRS2-FM1-PM3. Transsulfuration belongs to BRS2-FM2-PM5.
The integrated FM narrative for methylation cycle efficiency belongs on BRS2(FM1). This PM represents the throughput-and-balance node that those sibling PMs compose.
(Integration within BRS2)
This PM integrates flux across BRS2(FM1), constrained by both BRS2(KC1) and BRS2(KC2). Cycle balance connects remethylation arms (PM1, PM2) with SAMe output (PM3) and the transsulfuration branch (FM2-PM5) that competes for homocysteine routing.
5.1 Evidence Highlights
Introduction/Summary
Evidence for this PM spans foundational methylation biochemistry, experimental methionine-balance interventions, and human associations in which homocysteine marks cycle strain. Strong preclinical metabolic evidence does not equal a human methionine-restriction prescription for brain health.
- Confidence: low-medium
- Evidence Level: preclinical
- Rationale: In aged mice, a predominantly plant-based low-amino-acid longevity diet with moderate methionine supplementation reduced frailty and fat mass while preserving favourable metabolic signalling; too little or too much methionine abolished benefits [Fanti et al., 2026]. The human arm was large-scale epidemiology of plant-leaning patterns, not a methionine intervention trial. MetR reviews similarly show potent experimental metabolic effects while emphasising limited continuous human MetR feasibility [Parkhitko et al., 2026]. For BRAIN, the implication is methionine adequacy within amino-acid balance, not deliberate restriction or open-ended high methionine intake.
- Key References:
- Confidence: medium
- Evidence Level: mechanistic
- Rationale: Foundational biochemistry establishes SAM as the principal methyl donor and SAH as a potent product inhibitor of SAM-dependent methyltransferases, so methylation potential reflects SAM supply relative to SAH-mediated constraint rather than SAM production in isolation [Chiang et al., 1996]. This anchors PM4’s ownership of integrated cycle flux beyond remethylation or SAMe synthesis alone.
- Key References:
- Confidence: low-medium
- Evidence Level: observational
- Rationale: Reviews link elevated homocysteine to cognitive decline contexts and show folate/B12 combinations lower homocysteine — useful as evidence that multi-step cycle coverage affects a practical junction marker [Luzzi et al., 2022; Yu et al., 2020; Collaboration, 1998]. For this PM, the interpretive claim is readout-of-flux, not “homocysteine clearance is the mechanism.”
- Key References:
6. BRS Pathways and Connections
6.1 BRS Pathways
- None listed
6.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS1-FM2-PM5 — Acetylcholine Synthesis Support — SAMe-dependent PEMT methylation
- BRS1-FM3-PM6 — Neuronal Membrane DHA Incorporation — Membrane methylation context downstream of one-carbon flux
6.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS2-FM1-PM1 - Folate/B12-Dependent Homocysteine Remethylation
- BRS2-FM1-PM2 - Betaine/BHMT Remethylation
- BRS2-FM1-PM3 - SAMe Synthesis
- BRS2-FM2-PM5 - Transsulfuration Pathway
7. Scoreable Inputs & Modulation Signals
| Input Category | Example Inputs | PM relevance |
|---|---|---|
| Functional Property Potentials | methionine_adequacy_context; methyl_donor_pattern; sulfur_amino_acid_balance | May support balanced methionine-cycle flux. |
| Realised Functional States | consistent_daily_methyl_donor_coverage; protein_amino_acid_balance_pattern | May reflect meal-level pathway support without methionine maximisation. |
| Preparation Transformations | minimally_processed; whole_food_matrix | May preserve nutrient density for pathway support. |
8. References
- Aragão et al. (2024) — Unveiling Its Timeless Significance in Human Physiology and Health
- Chiang et al. (1996) — S-Adenosylmethionine and Methylation
- Fanti et al. (2026) — Methionine-Supplemented Longevity Diet Increases Growth Hormone, GLP-1, and FGF21
- Parkhitko et al. (2026) — Methionine Restriction and Mimetics to Ameliorate Human Aging and Disease
- Kumar and Yadav (2017) — The Transsulfuration Pathway
- Collaboration (1998) — Lowering Blood Homocysteine with Folic Acid Based Supplements
- Yu et al. (2020) — Evidence-based Prevention of Alzheimer's Disease
- Luzzi et al. (2022) — Homocysteine, Cognitive Functions, and Degenerative Dementias
- Lukovac et al. (2024) — Implications of Homocysteine, Vitamin B12, Vitamin D, Ferritin, and Iron Levels
- Wang et al. (2019) — Path Analysis for a Case-Control Study
- Tao Huang et al. (2015) — A Randomized Controlled Trial